Australia first for Hansa’s Idefirix in commercial kidney tr...
Hansa has announced that the first commercial patient in Australia has received a living donor kidney transplant following treatment with Idefirix.
After failure in sickle cell, Fulcrum merges with Slate
Following the failure of its sickle cell programme, Fulcrum Therapeutics will merge with Slate Medicines to advance Slate's migraine therapy.
Sanofi to lay off 229 Blueprint employees, close offices
A year after its $9.1bn acquisition of Blueprint Medicines, Sanofi is moving out of Blueprint's Cambridge, MA offices and letting 229 employees go.
OpenAI Foundation pledges $100m to boost hepatitis C cure ra...
The OpenAI Foundation has committed $100m to help fund a new public health initiative initially focused on hepatitis C.
Capricor’s DMD hope still strong, as it shares financials
Capricor shares second quarter financials as FDA reconsiders BLA for DMD therapy deramiocel.
Sales & Marketing
Digital
Market Access
Oncology
Patients
R&D
Partner Content
The Pharmaceutical Launch Excellence Summit
Where pharma leaders share strategies for successful drug launches.
Inizio Launches Connected Insights to Transform Global Medic...
Expanded APAC expertise, enhanced global infrastructure, and AI-enabled innovation to help life sciences organizations
9th Lab Asset & Facility Management Summit
Enabling Leaner, Smarter & More Resilient R&D Labs
The Evolution Summit Announces September 2026 Program for Cl...
Marcus Evans announces The Evolution Summit, taking place September 28-29, 2026 at Park Hyatt Aviara Resort, Golf Club & Spa, San Diego, CA.
Register Now for AAPS PharmSci 360!
Learn from pharmaceutical scientists involved at every stage of the drug development pipeline at PharmSci 360.